Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity.

Bushnell DM, Martin ML, McCarrier K, Gordon K, Chiou CF, Huang X, Ortmeier B, Kricorian G.

J Dermatolog Treat. 2013 Oct;24(5):356-60. doi: 10.3109/09546634.2012.742950. Epub 2012 Dec 8.

PMID:
23092173
2.

Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.

Martin ML, McCarrier KP, Chiou CF, Gordon K, Kimball AB, Van Voorhees AS, Gottlieb AB, Huang X, Globe D, Chau D, Viswanathan HN, Kricorian G.

J Dermatolog Treat. 2013 Aug;24(4):255-60. doi: 10.3109/09546634.2012.759639. Epub 2013 Jun 20.

PMID:
23249143
3.

Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis.

Revicki DA, Jin Y, Wilson HD, Chau D, Viswanathan HN.

J Dermatolog Treat. 2014 Feb;25(1):8-14. doi: 10.3109/09546634.2013.769042. Epub 2013 Jun 11.

PMID:
23339373
4.

Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis.

Wilson HD, Mutebi A, Revicki DA, Mease PJ, Genovese MC, Erondu N, Nirula A, Yuan FJ, Viswanathan HN.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1750-6. doi: 10.1002/acr.22653.

PMID:
26206134
5.

Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory.

Bushnell DM, Martin ML, Scanlon M, Chen T, Chau D, Viswanathan HN.

Qual Life Res. 2014 Apr;23(3):897-906. doi: 10.1007/s11136-013-0527-1. Epub 2013 Sep 20.

PMID:
24052326
6.

Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.

Shikiar R, Bresnahan BW, Stone SP, Thompson C, Koo J, Revicki DA.

Health Qual Life Outcomes. 2003 Oct 8;1:53.

7.
8.

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.

Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA.

Health Qual Life Outcomes. 2006 Sep 27;4:71.

9.

Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.

He Z, Lu C, Basra MK, Ou A, Yan Y, Li L.

J Eur Acad Dermatol Venereol. 2013 Jan;27(1):109-15. doi: 10.1111/j.1468-3083.2011.04371.x. Epub 2011 Dec 7.

PMID:
22145712
10.

Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.

Mathias SD, Feldman SR, Crosby RD, Colwell HH, McQuarrie K, Han C.

J Dermatolog Treat. 2016 Aug;27(4):322-7. doi: 10.3109/09546634.2015.1114567. Epub 2015 Dec 4.

PMID:
26634943
11.

[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].

Zanello A, Weber Rouget B, Gex-Fabry M, Maercker A, Guimon J.

Encephale. 2006 Jan-Feb;32(1 Pt 1):45-59. French.

PMID:
16633290
12.

Item-level psychometric properties for a new patient-reported psoriasis symptom diary.

Strober BE, Nyirady J, Mallya UG, Guettner A, Papavassilis C, Gottlieb AB, Elewski BE, Turner-Bowker DM, Shields AL, Gwaltney CJ, Lebwohl M.

Value Health. 2013 Sep-Oct;16(6):1014-22. doi: 10.1016/j.jval.2013.07.002.

13.

Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.

Kimball AB, Naegeli AN, Edson-Heredia E, Lin CY, Gaich C, Nikaï E, Wyrwich K, Yosipovitch G.

Br J Dermatol. 2016 Jul;175(1):157-62. doi: 10.1111/bjd.14464. Epub 2016 May 8.

PMID:
26852717
14.

Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis.

Safikhani S, Sundaram M, Bao Y, Mulani P, Revicki DA.

J Dermatolog Treat. 2013 Feb;24(1):50-9. doi: 10.3109/09546634.2011.631980. Epub 2011 Nov 10.

PMID:
22007701
15.

Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.

Fernandez-Peñas P, Jones-Caballero M, Espallardo O, García-Díez A.

Br J Dermatol. 2012 Apr;166(4):884-7. doi: 10.1111/j.1365-2133.2012.10806.x.

PMID:
22229951
16.

Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.

Dauden E, Herrera E, Puig L, Sánchez-Carazo JL, Toribio J, Caloto MT, Nocea G, Roset M, Lara N.

Health Qual Life Outcomes. 2012 May 24;10:56.

17.

The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).

Alexander M, Berger W, Buchholz P, Walt J, Burk C, Lee J, Arbuckle R, Abetz L.

Health Qual Life Outcomes. 2005 Oct 31;3:67.

18.

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.

Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooäär I, Heiberg T, Bertheussen H, Cañete JD, Sánchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Békés G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK; EULAR PsAID Taskforce.

Ann Rheum Dis. 2014 Jun;73(6):1012-9. doi: 10.1136/annrheumdis-2014-205207.

PMID:
24790067
19.

Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity.

Cappelleri JC, Bushmakin AG, Harness J, Mamolo C.

Qual Life Res. 2013 Nov;22(9):2489-99. doi: 10.1007/s11136-013-0384-y. Epub 2013 Mar 9.

PMID:
23475691
20.
Items per page

Supplemental Content

Write to the Help Desk